Skip to main content

UBS Group AG

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ACRV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$78,052
+$29,912 QoQ
Shares Held
43,850
+26.6% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 46 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACRV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ACRV ranks #373 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRV

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $78,052 43,850
2026-03-31 $48,140 34,634
2025-12-31 $839,983 348,541
2025-09-30 $1,236,624 683,218
2025-06-30 $541 455
2025-03-31 $26,162 12,888
2024-12-31 $85,585 14,217
2024-09-30 $39,634 5,662
2024-06-30 $64,681 11,152
2024-03-31 $91,126 12,745
2023-09-30 $975 102
2023-06-30 $126,748 9,780
2023-03-31 $68,475 5,396
2022-12-31 $54,696 4,748